IMA. Isometric dose-response relations of vascular segissue.
Since the experiments of Furchgott and Zawadzki [1] at bosentan, the ET antagonist BQ-123 or the ET antago-A B the end-seventies, there is an increased number of research nist BQ-788. After blocking the ET receptor, the endoprojects on the endothelium and the endothelial function in thelium-mediated relaxation by acetylcholine was signifivascular regulation. The experimental data produced then cantly augmented, independent of the type of ET-antagohas reached tremendous quantities. Now we know that the nist. endothelium plays a role as an autocrine and paracrine Based on these findings the conclusion has been made producer of vascular active substances [2], either with a that improving the endothelial function of coronary artery constricting or a dilating effect of blood vessels, either grafts by ET-receptor blocking, may promote thromdirectly or indirectly acting. Irregularities in this balance boresistance, decrease peri-perative vasospasm and impede could be responsible for increased tone in vascular smooth IMA atherosclerosis [4] . muscle cells, altered reactivity and vasomotion, and over a A few restrictions have to be made in interpretation of longer period to changes in structure and geometry and to the results of the study mentioned above. First, the enhanced platelet aggregation.
population of patients undergoing bypass surgery showed One of the most potent vasoactive agents found to be to have a clustering of coronary artery disease risk factors produced in the vascular endothelium, are the so-called and is a normal representation of the patient population endothelins (ET). This group of vasoactive polypeptides undergoing bypass surgery. Hence to find patients with contains different subgroups with subsequent different only one risk factor like diabetes, hypertension, smoking, receptor subtypes. Two receptor subtypes have been obesity or a familiar hyperlipidemia, is extremely difficult cloned in blood vessels, namely, the ETA receptor, which and would need huge patient populations. Therefore, the preferentially binds ET-1 and the ETB receptor, which results as presented in the paper could be mixed up with equally binds ET-1 and ET-3 [3] . different influences to the endothelium and therefore The manuscript of Verma et al. in this issue [4] describes possibly associated with different levels of endothelins in experiments on isolated segments (in vitro) of the human the blood. Thus no differentiation can be made between the internal mammary arteries (IMA) used in coronary bypass relative roles of each individual risk factor in endothelial surgery. It has been showed before that endothelin antago-dysfunction. nists inhibit ET-1 mediated constriction of the IMA [3],
A second heterogeneity can be found in the medication but it was unknown whether these endothelin antagonists as used by the patients. Especially the ACE-1 and calcium can improve the endothelial function. Therefore the au-channel blockers can have long lasting effects on endothors examined the effects of specific and non-specific thelial receptors and therefore interfere with the found ET-receptor antagonists on the endothelial function, as results. assessed by using acetylcholine-induced vasodilatation in Despite these restrictions in extrapolating the results from the in-vitro situation of the laboratory to a clinical conclusion, there is an important finding: it has been *Corresponding author. Tel.: 131-20-566-3325; fax: 131-20-697shown for the first time, that ET-receptor blockade im-
9441.
E-mail address: n.hoogerwerf@amc.uva.nl (N. Hoogerwerf).
proves endothelial dilating function in human IMA.
The IMA is the conduit of choice for coronary revascu-findings. More animal studies have to be done also to larization, because of its long term patency [5] and examine whether there is a possibility to implement thrombo-resistance as compared to saphenous veins or present findings of Verma et al. [4] into clinical use of other arteries. However, it does have a small diameter, these endothelin receptor blockers. leading to high blood velocities which maybe is the cause of peri-operative vasospasm. The latter is a critical factor in postoperative infarction and mortality following CABG References surgery, as recently shown again in a case report [6] where 3 patients were described with severe postoperative cor- be done to clarify possible interactions with current
